- $378.97m
- $538.22m
- $342.65m
- 85
- 52
- 66
- 76
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 16.36 | ||
PEG Ratio (f) | 0.17 | ||
EPS Growth (f) | 2,112.04% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.25 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 29.16 | ||
Price to Sales | 1.11 | ||
EV to EBITDA | 14.49 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.39% | ||
Return on Equity | -11.07% | ||
Operating Margin | 2.38% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 264.49 | 280.63 | 326.65 | 339.44 | 342.65 | 352.63 | 373.94 | 4.52% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -10.88 | -0.95 | +35.13 | n/a | n/a | n/a | +24.93 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
Directors
- Glenn Tobin NEC (59)
- John Boyd Douglas CEO (54)
- Matthew Chambless CFO (40)
- Christopher Fowler COO (45)
- Troy Rosser SVP (56)
- Robert Hinckle SVP (51)
- David Dye DRC (51)
- Regina Benjamin IND (64)
- Christopher Hjelm IND (59)
- Charles Huffman IND (67)
- Denise Warren IND (59)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 13th, 2002
- Public Since
- May 21st, 2002
- No. of Shareholders
- 81
- No. of Employees
- 3,200
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 14,949,387

- Address
- 54 St. Emanuel Street, MOBILE, 36602
- Web
- https://trubridge.com/
- Phone
- +1 2516398100
- Auditors
- Grant Thornton LLP
Upcoming Events for TBRG
Q1 2025 TruBridge Inc Earnings Release
TruBridge Inc Annual Shareholders Meeting
Q2 2025 TruBridge Inc Earnings Release
Similar to TBRG
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 23:47 UTC, shares in Trubridge are trading at $25.35. This share price information is delayed by 15 minutes.
Shares in Trubridge last closed at $25.35 and the price had moved by +222.93% over the past 365 days. In terms of relative price strength the Trubridge share price has outperformed the S&P500 Index by +198.08% over the past year.
The overall consensus recommendation for Trubridge is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreTrubridge does not currently pay a dividend.
Trubridge does not currently pay a dividend.
Trubridge does not currently pay a dividend.
To buy shares in Trubridge you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $25.35, shares in Trubridge had a market capitalisation of $378.97m.
Here are the trading details for Trubridge:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: TBRG
Based on an overall assessment of its quality, value and momentum Trubridge is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Trubridge is $29.20. That is 15.19% above the last closing price of $25.35.
Analysts covering Trubridge currently have a consensus Earnings Per Share (EPS) forecast of $1.44 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trubridge. Over the past six months, its share price has outperformed the S&P500 Index by +107.6%.
As of the last closing price of $25.35, shares in Trubridge were trading +37.7% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Trubridge PE ratio based on its reported earnings over the past 12 months is 16.36. The shares last closed at $25.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Trubridge's management team is headed by:
- Glenn Tobin - NEC
- John Boyd Douglas - CEO
- Matthew Chambless - CFO
- Christopher Fowler - COO
- Troy Rosser - SVP
- Robert Hinckle - SVP
- David Dye - DRC
- Regina Benjamin - IND
- Christopher Hjelm - IND
- Charles Huffman - IND
- Denise Warren - IND